Testing KDS2010 for early Alzheimer's memory loss
Part of Mental health clinical trials.
This study tests a new drug called KDS2010 for people with early Alzheimer's or mild memory loss. It aims to see if the drug can slow thinking and memory decline. You will need a caregiver to help with visits and must have a special brain scan showing amyloid plaques.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old
- You have mild memory problems (called mild cognitive impairment or very early Alzheimer's) and a brain scan showed amyloid plaques
- You have a caregiver who can come to study visits and answer questions about you
- You are not taking any Alzheimer's medications, or you are on a stable dose and willing to continue it
- You must agree to avoid certain medicines, including some antidepressants, and you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental tablet called RP902 for people with mild cognitive impairment (early memory and thinking problems). The goal is to see if it can safely help slow down memory decline.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This study tests whether a medicine called NPC-1 can help people with mild memory or thinking problems or early-stage Alzheimer's. It looks at a blood marker to see if the treatment may slow down the disease.
This study tests an experimental drug for Alzheimer's called NTRX-07. It aims to see if it can slow memory decline for people with mild to moderate Alzheimer's.
This study tests an oral tablet (TTYP01) for people with early Alzheimer's disease. It aims to see if the drug can slow memory loss. You must have a study partner who can support you throughout the trial.
This trial tests a new medicine, VHB937, in people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow down memory loss and thinking problems.
Hear when a new Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.